Hims & Hers Health
HIMS
Hims & Hers Health (HIMS) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.37
- EPS estimate
- −$0.05
- EPS surprise
- −642.97%
- Revenue surprise
- +7.77%
- Revenue
- $753.2M
- Revenue estimate
- $698.9M
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$0.05 | −$0.37 | −642.97% | $753.2M | SEC |
| Q1 2026 | May 11, 2026 | $0.03 | −$0.40 | −1674.80% | $608.1M | SEC |
| Q4 2025 | Feb 23, 2026 | $0.04 | $0.08 | +100.50% | $617.8M | SEC |
| Q3 2025 | Nov 3, 2025 | $0.09 | $0.06 | −36.37% | $599.0M | SEC |
| Q2 2025 | Aug 4, 2025 | $0.15 | $0.17 | +12.73% | $544.8M | SEC |
| Q1 2025 | May 5, 2025 | $0.12 | $0.20 | +65.43% | $586.0M | SEC |
| Q4 2024 | Feb 24, 2025 | $0.11 | $0.11 | −2.91% | $481.1M | SEC |
| Q3 2024 | Nov 4, 2024 | $0.11 | $0.32 | +187.77% | $401.6M | SEC |
| Q2 2024 | Aug 5, 2024 | $0.04 | $0.06 | +34.53% | $315.6M | SEC |
| Q1 2024 | May 6, 2024 | $0.01 | $0.05 | +385.44% | $278.2M | SEC |
| Q4 2023 | Feb 26, 2024 | −$0.02 | $0.01 | +144.84% | $246.6M | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.04 | −$0.04 | −12.04% | $226.7M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.05 | −$0.03 | +38.14% | $207.9M | SEC |
| Q1 2023 | May 8, 2023 | −$0.02 | −$0.05 | −142.72% | $190.8M | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.06 | −$0.05 | +14.53% | $167.2M | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.10 | −$0.09 | +11.24% | $144.8M | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.08 | −$0.10 | −23.15% | $113.6M | SEC |
| Q1 2022 | May 9, 2022 | −$0.08 | −$0.08 | +3.73% | $101.3M | SEC |
| Q4 2021 | Feb 22, 2022 | −$0.09 | −$0.15 | −68.92% | $84.7M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.08 | −$0.08 | +0.25% | $74.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Hims & Hers Health (HIMS) last report earnings?
Hims & Hers Health last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did HIMS beat earnings estimates?
No. Hims & Hers Health reported EPS of −$0.37 for Q2 2026 against a −$0.05 estimate — a 642.97% miss.
How much revenue did HIMS report last quarter?
Hims & Hers Health reported $753.2M in revenue for Q2 2026, against a consensus estimate of $698.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.